跳至主要内容
临床试验/NCT02949687
NCT02949687已完成不适用

Duodenal Ileal Interposition With Sleeve Gastrectomy and Selective Intra-Abdominal Denervation for Type 2 Diabetes Mellitus

Universidade Positivo0 个研究点目标入组 23 人开始时间: 2016年9月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
23
主要终点
glycated hemoglobin(HbA1c) level of 6.0% or less, without the use of diabetes medications

研究概览

简要总结

Surgical Treatment in Diabetic Patients With Grade 1 Obesity

详细描述

There will be a randomized clinical trial, non-blind, 1-arm treatment (Duodenal Ileal Interposition with Sleeve Gastrectomy and Selective Intra-Abdominal Denervation for Type 2 Diabetes Mellitus), including 40 research subjects with type 2 diabetes mellitus and obesity class I. In order to analise the effect on weight loss and glycemic control after 2 years of follow up

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Documented diagnosis of type 2 diabetes mellitus
  • Both sexes were treated with oral antidiabetic agents and / or insulin except the current treatment with Glucagon-like peptide-1 (GLP-1) receptor agonists or dipeptidyl peptidase 4 inhibitors
  • Stable antidiabetic medication within the last 8 weeks prior to randomization (V2), if therapy includes insulin, the average daily dose should not have changed by more than 10% in the past 8 weeks
  • HbA1c> 8.0%
  • Age> 20 years and <60 years
  • Body mass index (BMI) of 30 35 kg / m²
  • Agree to sign the consent form

排除标准

  • Type 1 diabetes mellitus (positive for anti-GAD), or GAD negative anti anti body with low β cell function (C-peptide after stimulation <0.5 ng / ml)
  • Current treatment with GLP-1 receptor agonist and / or dipeptidyl peptidase 4 inhibitors
  • Recent vascular event (myocardial infarction, coronary angioplasty or stroke in the past 6 months)
  • Malignant neoplasm
  • Portal hypertension
  • Inability to cooperate with segment
  • Low capacity of understanding surgery
  • Unrealistic expectations of the outcome
  • Cognitive impairment
  • Current pregnancy
  • Moderate or severe mood disorder; severe anxiety; eating disorders (based on Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria)
  • Chemical dependency or alcoholism (based on DSM-V criteria).

研究组 & 干预措施

ileal interposition sleeve sympathectomy

Experimental

laparoscopic ileal interposition with sleeve and sympathectomy

干预措施: ileal interposition with sleeve and sympathectomy (Procedure)

结局指标

主要结局

glycated hemoglobin(HbA1c) level of 6.0% or less, without the use of diabetes medications

时间窗: 2 YEARS

Success Rate of Biochemical Resolution of Diabetes at 24 Months as Measured by HbA1c ≤ 6% With no Diabetes Medications

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Luciana El-Kadre

invited clinical professor

Universidade Positivo

相似试验